Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) FCF Margin: 2009-2025

Historic FCF Margin for Aytu Biopharma (AYTU) over the last 17 years, with Sep 2025 value amounting to -4.45%.

  • Aytu Biopharma's FCF Margin rose 355.00% to -4.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.29%, marking a year-over-year increase of 214.00%. This contributed to the annual value of -3.26% for FY2025, which is 63.00% down from last year.
  • Per Aytu Biopharma's latest filing, its FCF Margin stood at -4.45% for Q3 2025, which was down 124.17% from 18.41% recorded in Q2 2025.
  • Aytu Biopharma's 5-year FCF Margin high stood at 146.11% for Q1 2021, and its period low was -38.11% during Q4 2021.
  • For the 3-year period, Aytu Biopharma's FCF Margin averaged around -0.47%, with its median value being -1.81% (2024).
  • Per our database at Business Quant, Aytu Biopharma's FCF Margin slumped by 18,378bps in 2022 and then soared by 5,634bps in 2023.
  • Over the past 5 years, Aytu Biopharma's FCF Margin (Quarterly) stood at -38.11% in 2021, then soared by 2,878bps to -9.33% in 2022, then spiked by 861bps to -0.72% in 2023, then soared by 1,859bps to 17.87% in 2024, then spiked by 355bps to -4.45% in 2025.
  • Its last three reported values are -4.45% in Q3 2025, 18.41% for Q2 2025, and -35.36% during Q1 2025.